Cas:118200-96-7 (2s)-(+)-2-methylglycidyl 4-nitrobenzoate manufacturer & supplier

Chemical Name:(2s)-(+)-2-methylglycidyl 4-nitrobenzoate

CAS.NO:118200-96-7

Synonyms:(S)-(2-methyloxiran-2-yl)methyl 4-nitrobenzoate;(S)-2-Methylglycidol 4-nitrobenzoate ester;Oxiranemethanol,2-methyl-,4-nitrobenzoate,(2S);(2S)-(+)-(2,3-Epoxy-2-methylpropylester)-4-nitrobenzoate;(S)-2-methylglycidyl 4-nitrobenzoate;2-Methyloxiranemethanol 4-nitrobenzoate (2S);MFCD00064535;(2S)-methyl-3-[4-nitrobenzoyl(oxy)]-1,2-epoxy-propane;(2S)-(+)-2-methylglycidyl-4-nitrobenzoate

Molecular Formula:C₁₁H₁₁NO₅

Molecular Weight:237.20900

HS Code:

Physical and Chemical Properties:

Melting point:87-89ºC(lit.)

Boiling point:375.9ºC at 760mmHg

Density:1.333g/cm3

Index of Refraction:1.565

PSA:84.65000

Exact Mass:237.06400

LogP:2.06370

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (S)-(2-methyloxiran-2-yl)methyl 4-nitrobenzoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-(+)-2-methylglycidyl-4-nitrobenzoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-2-methylglycidyl 4-nitrobenzoate Use and application,(S)-2-methylglycidyl 4-nitrobenzoate technical grade,usp/ep/jp grade.

Related News: The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. methyl 4-(5-(benzyloxy)-2-formyl-4-methoxyphenoxy)benzoate manufacturers The UK government has set out plans to make the UK the best destination in the world for researchers, making sure that it continues to attract the brightest and best from the UK and from overseas, cementing its status as a science superpower. 3-(5-cyclohexyl-1H-[1,2,4]triazol-3-yl)-naphthalen-2-ol suppliers We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.” 3-[2-allyl-4-(1-methyl-1-phenyl-ethyl)-phenoxy]-6-chloro-pyridazine vendor & factory Grégoire Boutonnet, Chief Operating Officer of NOVA, said: “I am thrilled to be joining the NOVA team at this exciting period of growth as we launch the Jinkō platform towards wider adoption in the clinical trial development space. ,We are committed to bringing safe, effective vaccines to Ireland and other markets as quickly as possible, and Charles River will continue to be an important partner in this regard.”